Emily C. Liang

972 total citations
45 papers, 514 citations indexed

About

Emily C. Liang is a scholar working on Oncology, Immunology and Epidemiology. According to data from OpenAlex, Emily C. Liang has authored 45 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 11 papers in Immunology and 10 papers in Epidemiology. Recurrent topics in Emily C. Liang's work include CAR-T cell therapy research (13 papers), Acute Lymphoblastic Leukemia research (6 papers) and Cytomegalovirus and herpesvirus research (6 papers). Emily C. Liang is often cited by papers focused on CAR-T cell therapy research (13 papers), Acute Lymphoblastic Leukemia research (6 papers) and Cytomegalovirus and herpesvirus research (6 papers). Emily C. Liang collaborates with scholars based in United States, China and Australia. Emily C. Liang's co-authors include Catherine A. Blish, Dara M. Strauss‐Albee, Alison L. Drake, Yi Yao, Julia Fukuyama, John Kinuthia, Ruth R. Montgomery, Susan Holmes, Justin A. Jarrell and Grace John‐Stewart and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Emily C. Liang

39 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emily C. Liang United States	12	165	121	101	80	76	45	514
Nianqiao Gong China	14	90 0.5×	189 1.6×	66 0.7×	92 1.1×	78 1.0×	58	682
S Mahajan India	13	454 2.8×	163 1.3×	96 1.0×	50 0.6×	24 0.3×	29	761
Lucia Lauková Austria	11	156 0.9×	217 1.8×	37 0.4×	56 0.7×	32 0.4×	22	452
Hanneke W. M. van Deutekom Netherlands	16	254 1.5×	327 2.7×	46 0.5×	40 0.5×	35 0.5×	27	724
Masatoshi Sakurai Japan	13	64 0.4×	105 0.9×	118 1.2×	93 1.2×	33 0.4×	69	497
Willem van Son Netherlands	5	81 0.5×	129 1.1×	50 0.5×	236 3.0×	47 0.6×	6	530
Taisei Suzuki Japan	12	90 0.5×	101 0.8×	56 0.6×	19 0.2×	25 0.3×	46	461
Yanping Huang China	12	247 1.5×	136 1.1×	65 0.6×	60 0.8×	13 0.2×	30	586
Sindhu Chandran United States	16	232 1.4×	236 2.0×	264 2.6×	96 1.2×	80 1.1×	43	1.0k
Hisaki Fujii Japan	15	148 0.9×	143 1.2×	155 1.5×	76 0.9×	114 1.5×	33	580

Countries citing papers authored by Emily C. Liang

Since Specialization

Citations

This map shows the geographic impact of Emily C. Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily C. Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily C. Liang more than expected).

Fields of papers citing papers by Emily C. Liang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily C. Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily C. Liang. The network helps show where Emily C. Liang may publish in the future.

Co-authorship network of co-authors of Emily C. Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Emily C. Liang. A scholar is included among the top collaborators of Emily C. Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily C. Liang. Emily C. Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Qian, et al.. (2025). A Practical Guide to Competing Risk Analysis for Transplant and Cell Therapy Research. Transplantation and Cellular Therapy.

Yang, Chen, Zheng‐Yi Zhou, Yu Zhou, et al.. (2024). 1722MO Updated efficacy results of olverembatinib (HQP1351) in patients with succinate dehydrogenase (SDH)-deficient gastrointestinal stromal tumors (GIST) and potential mechanisms of action (MOA). Annals of Oncology. 35. S1032–S1032. 3 indexed citations

Huang, Jennifer J., Emily C. Liang, Andrew J. Portuguese, et al.. (2024). Early prediction of severe ICANS after standard-of-care CD19 CAR T-cell therapy using gradient-boosted classification trees.. Journal of Clinical Oncology. 42(16_suppl). 7034–7034. 2 indexed citations

Huang, Jennifer J., Ryan Basom, Andrea Kalus, et al.. (2024). Autoimmune Outcomes in Patients with Concurrent Autoimmune Disease Receiving CD19 CAR T-Cell Therapy for Lymphoma. Blood. 144(Supplement 1). 7132–7132. 1 indexed citations

Liang, Emily C., Shipra Gandhi, Marilyn L. Kwan, et al.. (2024). Epidemiology of early vs late recurrence among women with early stage estrogen receptor–positive breast cancer in the Pathways Study. JNCI Journal of the National Cancer Institute. 116(10). 1621–1631. 1 indexed citations

Hathaway, Nicholas J., Emily C. Liang, Christian P. Nixon, et al.. (2024). Interchromosomal segmental duplication drives translocation and loss of P. falciparum histidine-rich protein 3. eLife. 13.

Liang, Emily C., Kai Rejeski, Teng Fei, et al.. (2024). Development and validation of an automated computational approach to grade immune effector cell-associated hematotoxicity. Bone Marrow Transplantation. 59(7). 910–917. 6 indexed citations

Liang, Emily C., Janise M. Roh, Cecile A. Laurent, et al.. (2024). A prospective study of vitamin D, proinflammatory cytokines, and risk of fragility fractures in women on aromatase inhibitors for breast cancer. Breast Cancer Research and Treatment. 208(2). 349–358.

Dekker, Simone E., Emily C. Liang, Andy Kaempf, et al.. (2023). Pre-Transplant Measurable Residual Disease By Next-Generation Sequencing Is a Better Predictor of Relapse Compared to BCR-ABL PCR in Adult Patients with Ph+ Acute Lymphoblastic Leukemia. Transplantation and Cellular Therapy. 29(2). S102–S103. 1 indexed citations

10.

Liang, Emily C., Simone E. Dekker, Amy Zhang, et al.. (2023). Trajectory of NGS MRD-Detected Clonotypes throughout the First Year Following Allogeneic Hematopoietic Cell Transplantation in Adult Acute Lymphoblastic Leukemia. Transplantation and Cellular Therapy. 29(2). S6–S6. 1 indexed citations

11.

Liang, Emily C., Alexandre V. Hirayama, Erik L. Kimble, et al.. (2023). Five-year follow-up update of defined-composition CD19 CAR T-cell therapy for relapsed/refractory CLL.. Journal of Clinical Oncology. 41(16_suppl). 7511–7511.

12.

Voutsinas, Jenna, Andrew J. Portuguese, Jennifer J. Huang, et al.. (2023). Factors Associated with Prolonged CRS and Neurotoxicity after Treatment with Axicabtagene Ciloleucel. Blood. 142(Supplement 1). 2126–2126. 1 indexed citations

13.

Portuguese, Andrew J., Emily C. Liang, Jennifer J. Huang, et al.. (2023). Lisocabtagene Maraleucel Versus Axicabtagene Ciloleucel: Efficacy and Toxicity in a Real-World Setting. Blood. 142(Supplement 1). 2131–2131. 2 indexed citations

14.

Guo, Shanchun, et al.. (2022). LncRNA HOTAIR sponges miR-301a-3p to promote glioblastoma proliferation and invasion through upregulating FOSL1. Cellular Signalling. 94. 110306–110306. 27 indexed citations

15.

Pickering, Harry, Joanna Schaenman, Maura Rossetti, et al.. (2022). T cell senescence and impaired CMV-specific response are associated with infection risk in kidney transplant recipients. Human Immunology. 83(4). 273–280. 8 indexed citations

16.

Schlick, Tamar, Stephanie Portillo‐Ledesma, Christopher G. Myers, et al.. (2021). Biomolecular Modeling and Simulation: A Prospering Multidisciplinary Field. Annual Review of Biophysics. 50(1). 267–301. 41 indexed citations

17.

Schaenman, Joanna, Maura Rossetti, Emily C. Liang, et al.. (2021). Leukocyte transcriptome indicators of development of infection in kidney transplant recipients. Clinical Transplantation. 35(4). e14252–e14252. 2 indexed citations

18.

Liang, Emily C., Lori Muffly, Parveen Shiraz, et al.. (2021). Use of Backup Stem Cells for Stem Cell Boost and Second Transplant in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation. Transplantation and Cellular Therapy. 27(5). 405.e1–405.e6. 5 indexed citations

19.

Schaenman, Joanna, Maura Rossetti, Gemalene Sunga, et al.. (2018). Association of pro-inflammatory cytokines and monocyte subtypes in older and younger patients on clinical outcomes after mechanical circulatory support device implantation. Human Immunology. 80(2). 126–134. 3 indexed citations

20.

Comer, Garet C., Emily C. Liang, & Julius A. Bishop. (2013). Lack of Proficiency in Musculoskeletal Medicine Among Emergency Medicine Physicians. Journal of Orthopaedic Trauma. 28(4). e85–e87. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact